① 只持有冠昊生物(300238)的收益为:-48.34%
② (300238 vs 600984)按1:1配对交易,对冲风险组合收益为:99.24%
③ (300238 vs 601100)按1:1配对交易,对冲风险组合收益为:93.35%
④ (300238 vs 600359)按1:1配对交易,对冲风险组合收益为:78.45%
⑤ (300238 vs 603916)按1:1配对交易,对冲风险组合收益为:76.88%
⑥ (300238 vs 600246)按1:1配对交易,对冲风险组合收益为:75.46%
⑦ (300238 vs 600720)按1:1配对交易,对冲风险组合收益为:71.93%
⑧ (300238 vs 002271)按1:1配对交易,对冲风险组合收益为:64.84%
⑨ (300238 vs 002684)按1:1配对交易,对冲风险组合收益为:63.31%
ⓐ (300238 vs 600371)按1:1配对交易,对冲风险组合收益为:63.23%
ⓑ (300238 vs 600186)按1:1配对交易,对冲风险组合收益为:60.88%